You've decided to move forward. Your child has been evaluated, the clinical team has confirmed eligibility, and the first dose is scheduled. Now what?
The first month is about adjustment, not transformation. Your child's body is learning to respond to the medication, and the clinical team is learning how your child responds. Here's what that looks like, week by week.
Before the first dose
Your child's physician will have already completed:
The medication arrives at your home. Your care team walks you through injection technique (it's a small, painless subcutaneous injection, similar to an EpiPen) and answers any last questions.
Week by week
Wondering if this applies to your child? The 2-minute eligibility check tells you if Thryvwell could be a fit. No commitment, no payment info.
What's normal (and what's not)
Normal in the first month
- • Mild nausea (especially after eating large meals)
- • Reduced interest in snacking
- • Feeling full faster than usual
- • Slight fatigue in week 1
- • Modest or no weight change yet
Contact your care team if
- • Persistent vomiting (not just nausea)
- • Severe abdominal pain
- • Signs of dehydration
- • Your child refuses to eat for more than a day
- • Mood changes that concern you
Your care team is available between appointments. You don't need to wait for a scheduled visit to ask a question or report a concern. That's the point of comprehensive care: support when you need it, not just when it's scheduled.
Setting realistic expectations
The first month is not when dramatic results happen. That's by design. The clinical protocol prioritizes safety and tolerance over speed. Here's a realistic picture:
The first month is about building the foundation. The results come from sustained treatment, consistent habits, and ongoing clinical support. Families who understand this from the beginning tend to have the best long-term outcomes.

Tips for the first 30 days

Sources
- Weghuber, D. et al. "Once-Weekly Semaglutide in Adolescents with Obesity." NEJM (2022)
- American Academy of Pediatrics. Clinical Practice Guideline for Obesity Treatment (2023)
- Novo Nordisk. Wegovy® Prescribing Information: Dosing and Administration
Ready to get started?
A free eligibility check takes less than 2 minutes. No commitment required.
The information on this page is for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting any treatment. Individual results may vary.

